10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 680,170 | 828,224 | 397,689 | 372,428 | 424,166 |
| Receivables | 51,208 | 36,026 | 22,726 | 30,851 | 33,371 |
| Inventories | 29,959 | 25,118 | 21,758 | 19,357 | 15,270 |
| TOTAL | $774,366 | $900,451 | $451,584 | $429,732 | $480,840 |
| Non-Current Assets | |||||
| PPE Net | 72,840 | 65,111 | 55,930 | 52,384 | 48,821 |
| Intangibles | 22,354 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 59,781 | 76,982 | 75,288 | 128,268 | 76,262 |
| TOTAL | $154,975 | $142,093 | $131,218 | $180,652 | $125,083 |
| Total Assets | $929,341 | $1,042,544 | $582,802 | $610,384 | $605,923 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 9,882 |
| Accounts payable and accrued liabilities | 4,709 | 9,490 | 9,916 | 13,505 | 13,028 |
| Accrued Expenses | 103,009 | 127,330 | 104,894 | 38,716 | 36,842 |
| TOTAL | $118,126 | $145,571 | $122,180 | $59,068 | $63,049 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 19,837 |
| Deferred Revenues | 4,472 | 3,775 | 3,432 | 3,394 | 3,297 |
| Other Non-Current Liabilities | 72,143 | 71,893 | 69,353 | 142,248 | 86,834 |
| TOTAL | $72,143 | $71,893 | $69,353 | $142,248 | $122,791 |
| Total Liabilities | $190,269 | $217,464 | $191,533 | $201,316 | $185,840 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 108,753 | 107,607 | 100,359 | 98,361 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -805,098 | -389,525 | -323,677 | -283,510 | -262,367 |
| Other shareholders' equity | -50 | -52 | 314 | -41 | -46 |
| TOTAL | $739,072 | $825,080 | $391,269 | $409,068 | $420,083 |
| Total Liabilities And Equity | $929,341 | $1,042,544 | $582,802 | $610,384 | $605,923 |